Vitamin D3 for Life

Live Enlightened

Article

FokI: From Receptor Structure to Context-Dependent Human Response

Previous related pageFokI Variants and Vitamin D Receptor Function: Study SummaryNext related pageImpact of Genetic Variation on VDR Signalling Efficiency: Evidence Synthesis
Study at a glance

How might the FokI variant change the vitamin D response?

FokI is a common genetic difference that produces longer or shorter versions of the vitamin D receptor. In some experiments, the shorter version worked more readily with another protein involved in turning gene instructions into a cell response.

Does a different response always mean there are more vitamin D receptors?

No. Studies of human immune cells found differences in some vitamin D responses without matching differences in receptor amount. The response also depended on the gene being measured and the study group.

Do human studies show one FokI variant is always better?

No. A study in children linked FokI variants with calcium absorption and bone measurements, but a study of diseased tissue from the glands that control blood calcium found no clear difference in the tested response between the gene forms. These findings do not show that one form is always better, or give a fixed response percentage for an individual.

Read the full article below ↓

The strengthened search identified a molecular bridge between the FokI receptor-length difference and downstream transcription, then extended the evidence into naturally genotyped human cells and physiological response.

TFIIB provides a mechanistic bridge

Jurutka and colleagues found that the shorter F/M4 VDR isoform interacted more efficiently with transcription factor IIB, or TFIIB, and showed greater transcriptional activity than the full-length f/M1 isoform in their experimental systems. Mutational experiments linked this difference to the VDR N-terminal region involved in interaction with the basal transcription machinery.

This supplies a specific molecular route through which a three-amino-acid receptor difference can influence transcription. It does not establish a universal efficiency advantage. It instead shows that receptor structure can alter one component of the transcriptional process while other receptor properties or biological endpoints remain context-dependent.

Natural human cells separate receptor abundance from receptor output

Work in healthy naturally genotyped human monocyte-macrophages added a different level of evidence. FokI genotype did not determine VDR mRNA or VDR protein abundance, yet vitamin-D-responsive target genes did not behave identically across genotype groups.

CAMP expression differed with FokI genotype, while CYP24A1 induction showed a genotype-by-ethnicity interaction. The material implication is that receptor abundance and downstream transcriptional response are not interchangeable measurements. Similar amounts of VDR do not guarantee identical responses at individual target genes.

The population interaction also argues against interpreting a FokI genotype as a fixed intrinsic response score. Genetic background, linkage structure and other population-dependent biology can modify the relationship between a receptor variant and the response that becomes experimentally visible.

The genotype signal can extend to human physiology

A human physiological study in healthy children used stable-isotope measurements of intestinal calcium absorption and found FokI-associated differences in calcium absorption and bone-mineral-density measures. Adjusted calcium absorption was reported as approximately 41.5% greater in FF than ff children.

This is not a direct measurement of receptor efficiency and should not be converted into a universal percentage advantage for one genotype. Calcium absorption is an organism-level phenotype influenced by multiple biological processes. Its importance is that genotype-associated differences can remain visible at a physiological level well beyond a reporter assay.

Human tissue evidence also supplies a genuine null

The strengthened search also found a useful counterexample. In cultured parathyroid tissue from patients with secondary hyperparathyroidism, calcitriol suppressed parathyroid-hormone secretion, but the tested FokI, ApaI, BsmI and TaqI genotypes did not significantly distinguish that response.

This null result prevents the positive human-cell and physiological findings from becoming a universal tissue rule. A genotype effect can be measurable at one transcriptional target or physiological endpoint and absent in another organ or disease context.

The newly earned conclusion is therefore more specific than saying that VDR genotype changes signalling efficiency. Common VDR variation can alter particular components of signalling, but the effect that becomes visible depends on the transcriptional target, cell type, tissue, population and physiological endpoint being measured.

New primary evidence

  • Jurutka PW et al. The Polymorphic N Terminus in Human Vitamin D Receptor Isoforms Influences Transcriptional Activity by Modulating Interaction with Transcription Factor IIB. Molecular Endocrinology. 2000;14(3):401-420. View the primary study.
  • O’Neill et al. Healthy primary human monocyte-macrophage study examining FokI genotype, VDR abundance, vitamin-D-responsive target genes and genotype-by-ethnicity interaction. View the primary study.
  • Ames et al. Human study using stable-isotope calcium-absorption measurements to examine FokI genotype and physiological response in healthy children. View the primary study.
  • Human parathyroid organ-culture study examining calcitriol suppression of parathyroid-hormone secretion across FokI, ApaI, BsmI and TaqI genotypes. View the primary study.

Related reading

Original sources

Source

View the primary study

Jurutka PW et al. The Polymorphic N Terminus in Human Vitamin D Receptor Isoforms Influences Transcriptional Activity by Modulating Interaction with Transcription Factor IIB.

Publication details

Jurutka PW et al. The Polymorphic N Terminus in Human Vitamin D Receptor Isoforms Influences Transcriptional Activity by Modulating Interaction with Transcription Factor IIB. Molecular Endocrinology. 2000;14(3):401-420. View the primary study.

Read more →
Source

View the primary study

Ames et al. Human study using stable-isotope calcium-absorption measurements to examine FokI genotype and physiological response in healthy children.

Publication details

Ames et al. Human study using stable-isotope calcium-absorption measurements to examine FokI genotype and physiological response in healthy children. View the primary study.

Read more →
Source

View the primary study

Human parathyroid organ-culture study examining calcitriol suppression of parathyroid-hormone secretion across FokI, ApaI, BsmI and TaqI genotypes.

Publication details

Human parathyroid organ-culture study examining calcitriol suppression of parathyroid-hormone secretion across FokI, ApaI, BsmI and TaqI genotypes. View the primary study.

Read more →